CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr — Stella

Recruiting

Back to Prostate Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

European Institute of Oncology, Milan

Key details

Sponsor

European Institute of Oncology

Enrollment target

~60 participants

Started

February 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Sex

Male only

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov